Highly efficient and specific regulation of gene expression using enhanced CRISPR-Cas12f system

Cited 1 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorY Oh-
dc.contributor.authorLee Wha Gwon-
dc.contributor.authorH K Lee-
dc.contributor.authorJ K Hur-
dc.contributor.authorKwang Hyun Park-
dc.contributor.authorK P Kim-
dc.contributor.authorS H Lee-
dc.date.accessioned2024-07-19T16:33:20Z-
dc.date.available2024-07-19T16:33:20Z-
dc.date.issued2024-
dc.identifier.issn0969-7128-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/35470-
dc.description.abstractThe recently developed CRISPR activator (CRISPRa) system uses a CRISPR-Cas effector-based transcriptional activator to effectively control the expression of target genes without causing DNA damage. However, existing CRISPRa systems based on Cas9/Cas12a necessitate improvement in terms of efficacy and accuracy due to limitations associated with the CRISPR-Cas module itself. To overcome these limitations and effectively and accurately regulate gene expression, we developed an efficient CRISPRa system based on the small CRISPR-Cas effector Candidatus Woesearchaeota Cas12f (CWCas12f). By engineering the CRISPR-Cas module, linking activation domains, and using various combinations of linkers and nuclear localization signal sequences, the optimized eCWCas12f-VPR system enabled effective and target-specific regulation of gene expression compared with that using the existing CRISPRa system. The eCWCas12f-VPR system developed in this study has substantial potential for controlling the transcription of endogenous genes in living organisms and serves as a foundation for future gene therapy and biological research.-
dc.publisherSpringer-Nature Pub Group-
dc.titleHighly efficient and specific regulation of gene expression using enhanced CRISPR-Cas12f system-
dc.title.alternativeHighly efficient and specific regulation of gene expression using enhanced CRISPR-Cas12f system-
dc.typeArticle-
dc.citation.titleGene Therapy-
dc.citation.number7-
dc.citation.endPage365-
dc.citation.startPage358-
dc.citation.volume31-
dc.contributor.affiliatedAuthorLee Wha Gwon-
dc.contributor.affiliatedAuthorKwang Hyun Park-
dc.contributor.alternativeName오윤선-
dc.contributor.alternativeName권이화-
dc.contributor.alternativeName이효민-
dc.contributor.alternativeName허준호-
dc.contributor.alternativeName박광현-
dc.contributor.alternativeName김기표-
dc.contributor.alternativeName이승환-
dc.identifier.bibliographicCitationGene Therapy, vol. 31, no. 7, pp. 358-365-
dc.identifier.doi10.1038/s41434-024-00458-w-
dc.description.journalClassY-
Appears in Collections:
Critical Diseases Diagnostics Convergence Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.